A detailed history of Allianz Se transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Allianz Se holds 94,033 shares of BMY stock, worth $4.4 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
94,033
Previous 94,623 0.62%
Holding current value
$4.4 Million
Previous $4.38 Billion 99.9%
% of portfolio
0.1%
Previous 0.1%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$43.31 - $48.98 $25,552 - $28,898
-590 Reduced 0.62%
94,033 $4.24 Million
Q2 2025

Aug 08, 2025

SELL
$44.12 - $59.6 $242,704 - $327,859
-5,501 Reduced 5.49%
94,623 $4.38 Billion
Q1 2025

May 09, 2025

SELL
$53.9 - $63.11 $62,685 - $73,396
-1,163 Reduced 1.15%
100,124 $6.11 Billion
Q4 2024

Feb 12, 2025

BUY
$51.92 - $59.94 $5.26 Million - $6.07 Million
101,287 New
101,287 $5.68 Billion
Q3 2024

May 12, 2025

BUY
$39.66 - $51.75 $976,548 - $1.27 Million
24,623 Added 24.21%
126,318 $6.54 Billion
Q2 2024

May 12, 2025

SELL
$40.25 - $52.99 $599,242 - $788,915
-14,888 Reduced 12.77%
101,695 $4.22 Billion
Q1 2024

May 12, 2025

BUY
$47.98 - $54.4 $789,702 - $895,369
16,459 Added 16.44%
116,583 $6.32 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Allianz Se Portfolio

Follow Allianz Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Se, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Se with notifications on news.